We envision a world where patients with cancer receive an effective drug the first time. About 30% of patients have mutations in their DNA that indicate they'll respond well to certain drugs; we develop drugs for the other 70%. We combined our drug, NMI-900, with a unique diagnostic that measures RNA rather than DNA. Our approach has the potential to select the right patient, improve survival, and limit side effects. In 5 years, we look forward to regulatory approval in AML and helping patients. Find out more at: https://wefunder.com/nemucore.medical.innovations.inc
View Top Employees from Nemucore Medical Innovations, Inc.Website | http://nemucore.com |
Revenue | $608000 |
Employees | 9 (9 on RocketReach) |
Founded | 2008 |
Address | One Hollis Street, Wellesley, Massachusetts 02482, US |
Phone | (508) 471-4647 |
Technologies |
JavaScript,
HTML,
jQuery
+8 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Biopharma, Drug Discovery, Manufacturing, Biotechnology, Drug Delivery, Health Care, Science and Engineering, Therapeutics |
Competitors | Andarix Pharmaceuticals, Arog Pharmaceuticals LLC, Phigenix, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Nemucore Medical Innovations, Inc. employee's phone or email?
The Nemucore Medical Innovations, Inc. annual revenue was $608000 in 2024.
David Williams is the Senior Vice President of Operations of Nemucore Medical Innovations, Inc..
9 people are employed at Nemucore Medical Innovations, Inc..
Nemucore Medical Innovations, Inc. is based in Wellesley, Massachusetts.
The NAICS codes for Nemucore Medical Innovations, Inc. are [325, 32, 3254, 32541].
The SIC codes for Nemucore Medical Innovations, Inc. are [283, 28].